Showing results (1091-1100 of 1,241) with videos related to

Sort By:
Pageof 125
Journal of the American Heart Association|October 30, 2018
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL TrialRobert J Mentz, M Angelyn Bethel, Peter Merrill, et al.
EFSA Journal. European Food Safety Authority|January 6, 2022
Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative in vitro metabolism studies, Antonio F Hernandez-Jerez, Paulien Adriaanse, et al.
JACC. Heart Failure|June 15, 2020
Splanchnic Nerve Block for Chronic Heart FailureMarat Fudim, Richard L Boortz-Marx, Arun Ganesh, et al.
Circulation|October 13, 2023
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER TrialJohn W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, et al.
The New England Journal of Medicine|September 21, 2023
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19David R Boulware, Christopher J Lindsell, Thomas G Stewart, et al.
American Heart Journal|May 23, 2023
Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVERAnkeet S Bhatt, Daniel Lindholm, Ann Nilsson, et al.
European Journal of Heart Failure|May 21, 2023
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA-HFSafia Chatur, Toru Kondo, Brian L Claggett, et al.
JACC. Heart Failure|August 20, 2025
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection FractionSara R O Siqueira, Maria A Pabon, Muthiah Vaduganathan, et al.
American Heart Journal|March 21, 2016
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trialRury R Holman, Mary Angelyn Bethel, Jyothis George, et al.
Journal of Cardiac Failure|April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF TrialBradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
Pageof 125